We are live on
!
Find out more
ZCM
Zebra Capital Management Portfolio holdings
AUM
$20M
1-Year Est. Return
2.24%
This Fund
S&P 500
This Quarter
Est. Return
+18.5%
1 Year Est. Return
+2.24%
3 Year Est. Return
+142.1%
5 Year Est. Return
+107.07%
10 Year Est. Return
+252.16%
AUM
$90.8M
AUM Growth
+$12M
(+15%)
Cap. Flow
+$4.91M
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
278
New
115
Increased
17
Reduced
37
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$2.15M |
| 2 |
Kelly Services Class A
KELYA
|
+$1.94M |
| 3 |
ESGR
Enstar Group
ESGR
|
+$1.61M |
| 4 |
LCI Industries
LCII
|
+$1.56M |
| 5 |
Upbound Group
UPBD
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WD-40
WDFC
|
+$1.47M |
| 2 |
Corcept Therapeutics
CORT
|
+$1.23M |
| 3 |
Veracyte
VCYT
|
+$1.22M |
| 4 |
Castle Biosciences
CSTL
|
+$1.03M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$965K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.12% |
| 2 | Industrials | 15.8% |
| 3 | Financials | 14.75% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Technology | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Blue Bird Corp
BLBD
$2.35B
| $451K | 0.5% |
+18,006
| New | +$411K |
|
77
Vericel Corp
VCEL
$2.35B
| $434K | 0.48% |
+7,815
| New | +$354K |
|
78
Halozyme
HALO
$9.79B
| $432K | 0.48% |
+10,359
| New | +$473K |
|
79
Hooker Furnishings Corp
HOFT
$150M
| $429K | 0.47% |
+11,760
| New | +$402K |
|
80
Radiant Logistics
RLGT
$386M
| $424K | 0.47% |
61,048
+3,237
| +6% | +$21.4K |
|
81
Universal Electronics
UEIC
$57.8M
| $418K | 0.46% |
7,618
+2,347
| +45% | +$135K |
|
|
AE
82
DELISTED
Adams Resources & Energy Inc
AE
| $409K | 0.45% |
+14,588
| New | +$408K |
|
83
Commault Systems
CVLT
$4.88B
| $404K | 0.44% |
6,257
-9,391
| -60% | -$597K |
|
84
Marten Transport
MRTN
$1.21B
| $396K | 0.44% |
+23,325
| New | +$394K |
|
85
Hawkins
HWKN
$2.67B
| $392K | 0.43% |
11,698
-448
| -4% | -$13.8K |
|
86
Vera Bradley
VRA
$97M
| $384K | 0.42% |
+38,020
| New | +$358K |
|
87
Myers Industries
MYE
$1.29B
| $381K | 0.42% |
+19,269
| New | +$413K |
|
|
LBC
88
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $378K | 0.42% |
+31,995
| New | +$343K |
|
89
CNB Financial Corp
CCNE
$1.04B
| $377K | 0.42% |
15,309
-12,480
| -45% | -$295K |
|
90
Perdoceo Education
PRDO
$1.99B
| $373K | 0.41% |
+31,200
| New | +$394K |
|
91
Daktronics
DAKT
$955M
| $371K | 0.41% |
59,225
+43,492
| +276% | +$246K |
|
92
Novanta
NOVT
$5.08B
| $367K | 0.4% |
+2,782
| New | +$366K |
|
|
CSII
93
DELISTED
Cardiovascular Systems, Inc.
CSII
| $359K | 0.4% |
9,371
-5,038
| -35% | -$214K |
|
|
SPNE
94
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $347K | 0.38% |
+19,933
| New | +$357K |
|
|
GLDD
95
DELISTED
Great Lakes Dredge & Dock
GLDD
| $346K | 0.38% |
+23,720
| New | +$346K |
|
96
Seneca Foods Class A
SENEA
$1.12B
| $341K | 0.38% |
+7,241
| New | +$346K |
|
97
South Plains Financial
SPFI
$845M
| $340K | 0.37% |
+14,946
| New | +$312K |
|
98
Puma Biotechnology
PBYI
$404M
| $333K | 0.37% |
+34,243
| New | +$382K |
|
|
EBTC
99
DELISTED
Enterprise Bancorp
EBTC
| $332K | 0.37% |
10,196
-2,276
| -18% | -$66.8K |
|
|
RBNC
100
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $332K | 0.37% |
+11,545
| New | +$265K |
|
Similar funds
CM
NPAM
6C
SCU
FFG
KE
GFT
CCM
Zebra Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Zebra Capital Management held 278 positions worth $90.8M, up 15% from $78.8M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Zebra Capital Management deployed $4.91M of net new capital in Q1 2021, opening 115 new positions and adding to 17 existing holdings. Its largest new stake was Emergent Biosolutions: 20,957 shares worth $1.95M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Veracyte, an estimated $1.22M trimmed.
- Zebra Capital Management's largest Q1 2021 buy was Emergent Biosolutions: 20,957 shares worth $1.95M.
- Zebra Capital Management added most to Rush Enterprises Class A in Q1 2021, an estimated $819K increase.
- Zebra Capital Management's biggest Q1 2021 reduction was Veracyte, cutting an estimated $1.22M.
- Zebra Capital Management fully exited WD-40 in Q1 2021, selling an estimated $1.47M.
- Zebra Capital Management's ten largest holdings make up 18% of its $90.8M portfolio in Q1 2021.
- Zebra Capital Management opened 115 new positions and closed 109 in Q1 2021.
- Zebra Capital Management's portfolio value rose 15% quarter-over-quarter to $90.8M.
Based on Zebra Capital Management's 13F filing for Q1 2021, filed 17 May 2021.